Popular Articles
Cellulite Treatment

San Diego Needle Exchange Program Examined
KPBS profiled San Diego"s "only clean syringe exchange program," a mobile van that twice weekly provides injection drug users with clean needles in exchange for used ones. The program also offers HIV and Hepatitis C tests and gives referrals to drug treatment programs. According to KPBS, "The concept behind syringe exchange is simple: people are going to shoot drugs. It"s crucial to make sure they have access to clean equipment, so they don"t spread blood-borne infections." However, the San Diego County Board of Supervisors is "adamantly opposed to the concept," and it is "illegal in San Diego for people to buy clean needles without a prescription," KPBS reports. In 2008, the privately-funded exchange program, which has the support of the mayor and the city council, collected more than 183,000 used syringes and handed out about 172,000 new ones (Goldberg, 7/7).
generic viagra online
NIH Deepens Investment In Combination Study Of MS Drugs
The first large-scale "CombiRX" clinical trial testing the combined use of FDA-approved interferon beta-1a (Avonex®) and glatiramer acetate (Copaxone®) to treat relapsing-remitting MS has just received a $19-million renewal grant from the National Institutes of Health. This is the largest MS trial ever supported by the NIH, with a cumulative investment of more than $44 million. The long-term trial is led by principal investigator Fred Lublin, MD, (Corinne Goldsmith Dickinson Multiple Sclerosis Center at Mount Sinai School of Medicine, New York, NY).
News of the day
Battles Loom Over Possible Funding Cuts For MRIs
A Battle looms over possible funding cuts for MRIs amid health care reform efforts.
Diagnostics

APhA Publishes New Print, CD-ROM Editions Of Handbook Of Pharmaceutical Excipients

The American Pharmacists Association (APhA) will publish this month the sixth edition of Handbook of Pharmaceutical Excipients and the corresponding single-user CD ROM, titled Pharmaceutical Excipients 6. Written by approximately 150 pharmaceutical scientists from around the world who are expert in pharmaceutical formulation or excipients manufacture, the new editions contain 340 fully referenced monographs on the most commonly used excipients in pharmaceutical dosage formulation. Forty monographs are new and all the monographs from the fifth edition have been completely revised and updated, many including NIR spectra. The 40 monographs new to this edition include glycine, hydroxypropyl betadex, methionine, neotame, pentetic acid, poly(DL-lactic acid), and tagatose. Each monograph consists of 22 categories of information: nonproprietary names, synonyms, chemical name and CAS registry number, empirical formula and molecular weight, structural formula, functional category, applications in pharmaceutical formulation or technology, description, pharmacopeial specifications, typical properties, stability and storage conditions, incompatibilities, method of manufacture, safety, handling precautions, regulatory status, related substances, comments, specific references, general references, author, and date of revision. Monographs are cross referenced and indexed so that excipients may be identified by chemical, nonproprietary, or trade names. Scanning electron microphotographs are included for many of the excipients. An appendix includes an expanded, completely updated list of worldwide suppliers of excipients that is organized alphabetically and geographically. Pharmaceutical Excipients 6 (single-user CD ROM) includes the complete text of 340 monographs with graphics. Other features: custom-written user interface; full text searching; hot-linked contents list, index, and suppliers" directory; copy and paste and printing facility. Pharmaceutical Excipients is also available online through MedicinesComplete. Trial and annual licenses are available for individuals, groups, or organizations. Pricing information is available from Sales@MedicinesComplete.com. The excipients references, published jointly by APhA and the Pharmaceutical Press, the publications department of the Royal Pharmaceutical Society of Great Britain, London, United Kingdom, are edited by Raymond C. Rowe, PhD, Paul J. Sheskey, BPharm, and Marian E. Quinn, MS. Rowe is Chief Scientist, Intelligensys Ltd., Stokesley, North Yorkshire, UK, and Professor of Industrial Pharmaceutics, School of Pharmacy, University of Bradford, UK; Sheskey is Application Development Leader in the Dow-Wolff Cellulosics R&D Group at The Dow Chemical Company, Midland, Michigan; and Quinn is Development Editor, The Pharmaceutical Press, London, UK. The regular price for the book (ISBN 978-1-135-2; 888 pages, hardbound) or CD ROM (978-1-58212-136-9) is $399.95 ($359.95 for APhA members). The book and CD-ROM are available as a package (ISBN 978-1-58212-137-6) for $599.95 ($539.95 for APhA members). Until August 31 prices are discounted, with the book or CD ROM selling for $375 ($337.50 for APhA members) and the book-CD ROM package selling for $550 ($495 for APhA members). Orders may be made through APhA"s toll-free order department (800-878-0729) or online via http://www.pharmacist.com. To obtain the discount through August 31, purchasers should use offer code D9005. American Pharmacists Association (APhA)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):